Clinical Trial Update: A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating the efficacy, safety, and tolerability of repeat-dose fasedienol nasal spray for acute treatment of social anxiety disorder in adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Fasedienol nasal spray (fasedienol)

Snippet

Sponsor: VistaGen Therapeutics, Inc. | Conditions: Social Anxiety Disorder | Phase 2 | Status: RECRUITING